Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatostatin receptor 1 (SSTR1) is a G protein-coupled receptor (GPCR) that mediates the inhibitory effects of somatostatin on hormone secretion and neuronal activity. It is primarily expressed in the jejunum, stomach, central nervous system, and peripheral tissues. SSTR1 plays roles in various physiological functions including growth hormone release, insulin/glucagon secretion, cell proliferation, gastric acid secretion, angiogenesis, and gastrointestinal motility. While not yet a primary drug target, its broad tissue distribution suggests potential therapeutic applications in metabolic regulation, gastrointestinal function, neurological diseases, and cancer.
Gi/o protein-mediated inhibition of adenylyl cyclase activity; Stimulation of phosphotyrosine phosphatase and Na+/H+ exchanger.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatostatin Receptor 1 (SSTR1).